Tuesday, August 28, 2018

Freight Forwarding Group Approved to Handle Colombian Drug Traffic

(and no, that's not like it sounds)
Shipping News Feature
COLOMBIA – The Colombian headquarters of Swiss freight forwarding and logistics group, Panalpina has been certified according to WHO Good Distribution Practice (GDP), an key international standard for the proper distribution of medicinal products for human use. The business unit in Bogotá is Panalpina's 31st location globally to obtain such an important certification for the healthcare industry.

Panalpina Bogotá has successfully completed a two-day audit by the inspection, verification, testing and certification company SGS, and is now certified according to that international World Health Organization certification. Angelo Dotto, Panalpina’s Managing Director for Colombia, commented:

“We are proud about this achievement, and this is great news for our healthcare customers who demand strict quality and temperature control measures in the supply chain to ensure the safety and integrity of their products. We see great growth potential in this business area, considering that the growth rate of this industry in Colombia is 5% per year.”

Colombia is Latin America’s fourth largest pharmaceutical market after Brazil, Mexico and Panama. Most of the major international pharmaceutical companies do business in the country with a population of 48 million people. Among the top 20 pharmaceutical companies in terms of revenue, there are also a handful of Colombian players with a domestic production, mainly of generic medicinal products, and the country's biodiversity is seen as a chance to develop pharmaceutical products from natural substances. 82% of Colombia’s pharmaceutical imports and 47% of the pharmaceutical exports run through the Bogotá region.

Panalpina entered the Colombian market in 1962 and today has own offices in Bogotá, Medellín, Cali, Cartagena, Barranquilla, and Pereira, as well as an agent office in Buenaventura. The company provides many of the world’s biggest pharmaceutical companies with international air and ocean freight as well as value-added logistics services.